Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 533)
Posted On: 02/05/2021 12:39:56 AM
Post# of 153898
Posted By: ohm20
Re: chazzledazzle #76368
Here's where the big screw up is in just gene editing out CCR5. In natural CCR5 delta 32 double allele gene absence other receptors will take over a large part of the load. Just gene editing out CCR5 would leave you in the same position as gene edited mice. You would be very susceptible to infections since the immune system is completely impaired.

Quote:
Does Leronlimab have a purpose or an effect in the cohort of people that do not express CCR5 receptors at all?



no

Quote:
Do any of the LL MOAs that are unrelated to CCR5 still have revelance in the cohort of people that do not express CCR5 receptors?



All the MOAs for leronlimab are related to CCR5.













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site